2022 - Research.com Best Female Scientist Award
Marcia L. Stefanick focuses on Internal medicine, Women's Health Initiative, Gynecology, Breast cancer and Hazard ratio. The Internal medicine study combines topics in areas such as Placebo and Endocrinology. Her study in Women's Health Initiative is interdisciplinary in nature, drawing from both Million Women Study, Hormone replacement therapy, Obstetrics, Diet therapy and Risk factor.
Her Gynecology research is multidisciplinary, incorporating perspectives in Hysterectomy, Observational study, Medroxyprogesterone acetate, Breast disease and Menopause. Her research in Breast cancer intersects with topics in Body mass index and Oncology. Her Hazard ratio research is multidisciplinary, incorporating elements of Absolute risk reduction, Hip fracture, Proportional hazards model, Surgery and Incidence.
The scientist’s investigation covers issues in Internal medicine, Women's Health Initiative, Hazard ratio, Gynecology and Breast cancer. Her Internal medicine research incorporates themes from Endocrinology and Oncology. Her studies in Women's Health Initiative integrate themes in fields like Physical therapy, Incidence, Gerontology, Medroxyprogesterone acetate and Hormone therapy.
Her Hazard ratio research integrates issues from Stroke, Lower risk, Hip fracture and Proportional hazards model. Her work deals with themes such as Hysterectomy, Menopause and Hormone replacement therapy, which intersect with Gynecology. Her work carried out in the field of Randomized controlled trial brings together such families of science as Placebo and Clinical trial.
Her primary areas of investigation include Internal medicine, Women's Health Initiative, Hazard ratio, Breast cancer and Body mass index. Her work is dedicated to discovering how Internal medicine, Oncology are connected with Ovarian cancer and Estrogen and other disciplines. The study incorporates disciplines such as Obstetrics, Randomized controlled trial, Disease and Clinical trial in addition to Women's Health Initiative.
Marcia L. Stefanick has included themes like Placebo, Proportional hazards model and Risk factor in her Hazard ratio study. In her research on the topic of Breast cancer, Hysterectomy is strongly related with Medroxyprogesterone acetate. Marcia L. Stefanick combines subjects such as Diabetes mellitus, Dual-energy X-ray absorptiometry, Weight gain, Bone density and Physical therapy with her study of Body mass index.
Marcia L. Stefanick mainly investigates Internal medicine, Women's Health Initiative, Body mass index, Breast cancer and Hazard ratio. Her Internal medicine study is mostly concerned with Cancer, Stroke, Prospective cohort study, Cohort study and Cohort. The Women's Health Initiative study combines topics in areas such as Weight loss, Weight change, Eye examination, Weight gain and Risk factor.
Her Body mass index research incorporates elements of Odds ratio, Diabetes mellitus, Bone density, Osteoporosis and Obstetrics. Her Breast cancer research includes themes of Mortality rate, Randomized controlled trial, Estrogen and Vasomotor. Her studies deal with areas such as Visual acuity, Cognitive test, Dementia, Visual impairment and Pediatrics as well as Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw;Garnet L. Anderson;Ross L. Prentice;Andrea Z. LaCroix.
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial
Garnet L. Anderson;Marian C. Limacher;Annlouise R. Assaf;Tamsen Bassford.
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial
Rowan T. Chlebowski;Susan L. Hendrix;Robert D. Langer;Marcia L. Stefanick.
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
Jacques E. Rossouw;Ross L. Prentice;JoAnn E. Manson;LieLing Wu.
Calcium plus vitamin D supplementation and the risk of fractures.
Rebecca D. Jackson;Andrea Z. LaCroix;Margery Gass;Robert B. Wallace.
The New England Journal of Medicine (2006)
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
Valery T. Miller;John LaRosa;Vanessa Barnabei;Craig Kessler.
Walking compared with vigorous exercise for the prevention of cardiovascular events in women.
Joann E. Manson;Philip Greenland;Andrea Z. LaCroix;Marcia L. Stefanick.
The New England Journal of Medicine (2002)
Low-fat dietary pattern and risk of cardiovascular disease : The women's health initiative randomized controlled dietary modification trial
Barbara V. Howard;Barbara V. Howard;Linda Van Horn;Judith Hsia;JoAnn E. Manson.
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
Jane A. Cauley;John Robbins;Zhao Chen;Steven R. Cummings.
Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study
Sally A. Shumaker;Claudine Legault;Lewis Kuller;Stephen R. Rapp.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: